Literature DB >> 28472318

Parainfluenza Virus 3-Specific T Cells: Opportunity for Intervention?

Alpana Waghmare1,2,3, Janet A Englund2,3, Michael Boeckh1,4.   

Abstract

Keywords:  Corticosteroids; Immune response; Parainfluenza virus; T cells; Transplantation

Mesh：

Year:  2017        PMID： 28472318      PMCID： PMC5854008          DOI： 10.1093/infdis/jix207

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  34 in total

1.  CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome.

Authors:  Cinja Sukdolak; Sabine Tischer; Daria Dieks; Constanca Figueiredo; Lilia Goudeva; Hans-Gert Heuft; Murielle Verboom; Stephan Immenschuh; Albert Heim; Sylvia Borchers; Eva Mischak-Weissinger; Rainer Blasczyk; Britta Maecker-Kolhoff; Britta Eiz-Vesper
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-23       Impact factor: 5.742

2.  Epidemiology of acute lower respiratory disease in children.

Authors:  P Glezen; F W Denny
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

3.  Parainfluenza 3 Infections Early After Kidney or Simultaneous Pancreas-Kidney Transplantation.

Authors:  I Helanterä; V-J Anttila; R Loginov; M Lempinen
Journal:  Am J Transplant       Date:  2017-01-03       Impact factor: 8.086

4.  Symptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation.

Authors:  Ashok Srinivasan; Chong Wang; Jie Yang; Jerry L Shenep; Wing H Leung; Randall T Hayden
Journal:  Biol Blood Marrow Transplant       Date:  2011-03-09       Impact factor: 5.742

5.  A parainfluenza virus type 3 outbreak at a residential aged care facility: The role of microbiologic testing in early identification and antimicrobial stewardship.

Authors:  Susan Ryan; Elizabeth Gillespie; Rhonda L Stuart
Journal:  Am J Infect Control       Date:  2016-09-21       Impact factor: 2.918

6.  Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.

Authors:  Natalie Mackow; Emérito Amaro-Carambot; Bo Liang; Sonja Surman; Matthias Lingemann; Lijuan Yang; Peter L Collins; Shirin Munir
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

7.  Multicluster nosocomial outbreak of parainfluenza virus type 3 infection in a pediatric oncohematology unit: a phylogenetic study.

Authors:  Antonio Piralla; Elena Percivalle; Alessandra Di Cesare-Merlone; Franco Locatelli; Giuseppe Gerna
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

8.  Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis.

Authors:  W Garrett Nichols; Dean D Erdman; Alison Han; Carol Zukerman; Lawrence Corey; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2004-01       Impact factor: 5.742

9.  Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes.

Authors:  S Seo; H Xie; R A Karron; B Thumar; J A Englund; W M Leisenring; T Stevens-Ayers; M Boeckh; A P Campbell
Journal:  Bone Marrow Transplant       Date:  2014-06-30       Impact factor: 5.483

10.  Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders.

Authors:  Nicola Lehners; Julia Tabatabai; Christiane Prifert; Marianne Wedde; Joe Puthenparambil; Benedikt Weissbrich; Barbara Biere; Brunhilde Schweiger; Gerlinde Egerer; Paul Schnitzler
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.